Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Venkata Edara and Mehul Suthar.
Venkata Edara
Connection Strength
2.935
Mehul Suthar
  1. Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination. JAMA. 2021 05 11; 325(18):1896-1898.
    View in: PubMed
    Score: 0.945
  2. Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant. Cell Host Microbe. 2021 04 14; 29(4):516-521.e3.
    View in: PubMed
    Score: 0.935
  3. Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies. Curr Protoc Immunol. 2020 12; 131(1):e116.
    View in: PubMed
    Score: 0.229
  4. Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection. PLoS One. 2021; 16(8):e0256482.
    View in: PubMed
    Score: 0.060
  5. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science. 2021 09 17; 373(6561):1372-1377.
    View in: PubMed
    Score: 0.060
  6. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Sci Transl Med. 2021 08 18; 13(607).
    View in: PubMed
    Score: 0.060
  7. A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Sci Immunol. 2021 07 15; 6(61).
    View in: PubMed
    Score: 0.060
  8. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021 08; 596(7872):410-416.
    View in: PubMed
    Score: 0.060
  9. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep Med. 2021 07 20; 2(7):100354.
    View in: PubMed
    Score: 0.060
  10. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. Cell Rep. 2021 07 13; 36(2):109353.
    View in: PubMed
    Score: 0.060
  11. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung. Nat Commun. 2021 06 11; 12(1):3587.
    View in: PubMed
    Score: 0.059
  12. Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain. J Immunol. 2021 06 01; 206(11):2605-2613.
    View in: PubMed
    Score: 0.059
  13. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 06; 594(7862):253-258.
    View in: PubMed
    Score: 0.059
  14. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India. Virology. 2021 06; 558:13-21.
    View in: PubMed
    Score: 0.058
  15. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity. 2021 03 09; 54(3):542-556.e9.
    View in: PubMed
    Score: 0.058
  16. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. Nat Commun. 2020 10 27; 11(1):5413.
    View in: PubMed
    Score: 0.057
  17. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N Engl J Med. 2020 12 17; 383(25):2427-2438.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.